Naturally Splendid (TSXV:NSP) announced it has closed the restated and amended licence agreement with Full Spectrum Laboratories Ltd. (FSL), a company controlled by Charles R. Brink, a director of Naturally Splendid, whereby the parties amended the terms of the licence agreement dated Nov. 17, 2015.
As quoted in the press release:

This filing marks the acceptance by the TSX Venture Exchange for the previously announced restated and amended license agreement. As a result of closing of the Restated and Amended License Agreement, Naturally Splendid acquired a one hundred percent (100%) interest, without royalty, in FSL’s omega technologies, including HempOmega(TM) and H2Omega(TM). In addition to hemp, the technology has the potential to transform flax, chia, canola, chia and algae into highly bioavailable water dispersible powders and aqueous solutions. FSL removed the minimum annual royalty of USD $1.6 million (the “Minimum Royalty”) that was set to commence after the second anniversary of the Original License Agreement and continue for ten (10) years for a total reduction of $16,000,000 CDN in guaranteed royalty payments. In consideration of owning a 100% interest in the omega technologies and the removal of the Minimum Royalty, Naturally Splendid extinguished its non-exclusive license of FSL’s bioreactor technology and changed its exclusive license on certain analytical testing SOPs and GC-MS Terpene Analysis SOPs to a non-exclusive license.


Naturally Splendid’s CEO Craig Goodwin states:

We anticipate that the outright acquisition of the omega technologies will greatly contribute to our corporate strategy of becoming a leading producer of value-added nutritional ingredient solutions. Secured ownership will allow us to explore out-licensing opportunities for HempOmega(TM) and other applications of the omega technologies.”Bryan Carson, Naturally Splendid’s VP of Operations added, “We are continuing to promote HempOmega(TM) as sustainable omega ingredient for the human, pet, livestock, and cosmetic industries. In initial studies, HempOmega(TM) demonstrated higher sustainability and bioavailability than unformulated omega oils. Our researchers will also begin to look at other plant oils that may be successfully encapsulated with this technology to create additional bioactive ingredients.

Connect withNaturally Splendid (TSXV:NSP) to receive an Investor Kit

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less

Achievements with Scalability and Compatibility Pave Way for Next Phase of Advancement

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is excited to announce that the Company’s holding, Arcology, a cluster-computing powered AI blockchain ecosystem with unlimited scalability, has updated its working roadmap in response to its Testnet 1.0 results

Keep reading... Show less